Urgent update for anyone who s had the Pfizer vaccine as cases of Delta variant spike dailypost.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypost.co.uk Daily Mail and Mail on Sunday newspapers.
UK-wide study focuses on threats of new SARS-CoV-2 variants
Industry News: UK-wide study focuses on threats of new SARS-CoV-2 variants
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
26 Jan 2021
A new national research project to study the effects of emerging mutations in SARS-CoV-2 was launched on 15 January. The £2.5 million UK Research and Innovation (UKRI)-funded G2P-UK National Virology Consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
Brazilian Covid variant found in the UK, scientist says. (PA) One of two coronavirus variants found in Brazil has been detected in the UK, according to a leading scientist and government advisor. The mutations are thought to make the virus more infectious and Prime Minister Boris Johnson has said he is “very concerned” about the variant, adding that extra measures are being put in place to prevent the variant being imported to the UK. On Thursday, Transport Secretary, Grant Schapps announced South America, Panama, Portugal and Cape Verde will be subject to a travel ban from 4am on Friday January 15 amid concerns over the new variant.
Date Time
National consortium to study threats of new SARS-CoV-2 variants
The University of Liverpool is part of a new national research project to study the effects of emerging mutations in SARS-CoV-2.
Supported by £2.5 million funding from UK Research and Innovation (UKRI), the ‘G2P-UK’ National Virology Consortium will study how mutations in the virus affect key outcomes such as how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
The consortium will bring together leading virologists from 10 research institutions including the University of Liverpool. They will work alongside the COVID-19 Genomics UK (COG-UK) consortium, which plays a world-leading role in virus genome sequencing, and Public Health England to boost the UK’s capacity to study newly identified virus variants and rapidly inform government policy.